Rench Wealth Management Inc. Buys 650 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Rench Wealth Management Inc. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,546 shares of the medical equipment provider's stock after purchasing an additional 650 shares during the period. Intuitive Surgical comprises 2.6% of Rench Wealth Management Inc.'s portfolio, making the stock its 12th biggest holding. Rench Wealth Management Inc.'s holdings in Intuitive Surgical were worth $7,592,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Bennett Selby Investments LP raised its stake in Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after buying an additional 17 shares in the last quarter. Onefund LLC grew its holdings in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after acquiring an additional 18 shares during the period. LVW Advisors LLC raised its position in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. lifted its stake in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC boosted its position in shares of Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after purchasing an additional 19 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company's stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded up $1.40 during trading on Friday, hitting $482.74. The company's stock had a trading volume of 1,618,989 shares, compared to its average volume of 1,589,481. The firm has a market cap of $171.94 billion, a price-to-earnings ratio of 75.31, a P/E/G ratio of 5.85 and a beta of 1.55. The company has a 50-day moving average of $522.23 and a 200-day moving average of $532.34. Intuitive Surgical, Inc. has a 12 month low of $364.31 and a 12 month high of $616.00.

Wall Street Analyst Weigh In

A number of analysts have recently commented on ISRG shares. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Wells Fargo & Company boosted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Evercore ISI lifted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Royal Bank of Canada increased their target price on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $611.81.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.